Showing results (71-80 of 152) with videos related to

Sort By:
Pageof 16
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 23, 2025
Normalization of subendometrial peristalsis in women with a large uterine niche following laparoscopic niche repair: A prospective cohort studySaskia J M Klein Meuleman, Yizhou Huang, Massimo Mischi, et al.
Facts, Views & Vision in Obgyn|March 19, 2026
Incisional hernia after specimen extraction in minimally invasive gynaecologic surgery: a systematic reviewJolanda van Keizerswaard, Renée H Visser, Freek A Groenman, et al.
Journal of Medical Internet Research|October 23, 2012
eHealth program to empower patients in returning to normal activities and work after gynecological surgery: intervention mapping as a useful method for developmentAntonie Vonk Noordegraaf, Judith A F Huirne, Carina A Pittens, et al.
Frontiers in Medicine|June 21, 2024
The added value of a face-to-face pan-European course-what makes it worth it?Robert de Leeuw, Judith A F Huirne, Christiano Rositto, et al.
Research and Practice in Thrombosis and Haemostasis|December 3, 2025
Heavy or healthy? Assessing menstrual bleeding and bleeding tendency in Dutch adolescentsAnne de Vaan, Habibe Özcan, Nicole B Burger, et al.
Human Reproduction (Oxford, England)|August 31, 2004
Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levelsJudith A F Huirne, Andre C D van Loenen, Roel Schats, et al.
Therapeutics and Clinical Risk Management|March 24, 2025
Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine FibroidsAnnika Semmler, Maria E de Lange, Joost P H Drenth, et al.
Human Reproduction (Oxford, England)|November 30, 2004
Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancyJudith A F Huirne, Andre C D van Loenen, Roel Schats, et al.
British Journal of Clinical Pharmacology|September 1, 2023
Considerations on implementation of the newest treatment for symptomatic uterine fibroids: Oral GnRH antagonistsMaria E de Lange, Annika Semmler, T Justin Clark, et al.
Human Reproduction (Oxford, England)|February 10, 2022
Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroidsMei-An Middelkoop, Maria E de Lange, T Justin Clark, et al.
Pageof 16